Tristan Baguet, PharmD

Janssen R&D
Steenhuffel, Vlaams-Brabant, Belgium

Disclosure(s): Johnson&johnson: Stocks/Bonds (Public Company)

Presentation(s):

• 319 - Single-Dose and Repeat Single-Dose Ascending Dose Study Evaluating Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza

  Friday, October 18, 2024
  12:30 PM – 12:35 PM US PT